Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals

OBJECTIVE: The aim of this study was to evaluate the dipeptidyl peptidase-IV (DPP-IV) inhibitor sitagliptin with respect to mode of inhibition and its in vivo duration of inhibition and efficacy in type 2 diabetes animal model. MATERIALS AND METHODS: DPP-IV enzyme assay was carried out in human plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Joseph A., Singh, Shuchita, Sethi, Sachin, Roy, Subhasis, Mittra, Shivani, Rayasam, Geetavani, Bansal, Vinay, Sattigeri, Jitendra, Ray, Abhijit
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941613/
https://www.ncbi.nlm.nih.gov/pubmed/20927248
http://dx.doi.org/10.4103/0253-7613.68425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941613/
https://www.ncbi.nlm.nih.gov/pubmed/20927248
http://dx.doi.org/10.4103/0253-7613.68425

Ejemplares similares